[Federal Register Volume 91, Number 32 (Wednesday, February 18, 2026)]
[Notices]
[Page 7542]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2026-03144]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Charter 
Renewal

AGENCY: Nuclear Regulatory Commission.

ACTION: Notice of renewal of the Charter of the Advisory Committee on 
the Medical Uses of Isotopes.

-----------------------------------------------------------------------

    The U.S. Nuclear Regulatory Commission (NRC) has determined that 
renewal of the charter for the Advisory Committee of the Medical Uses 
of Isotopes (ACMUI) until February 27, 2028, is in the public interest 
in connection with duties imposed on the Commission by law. This action 
is being taken in accordance with the Federal Advisory Committee Act, 
as amended, 5 U.S.C. chapter 10, after consultation with the Committee 
Management Secretariat, General Services Administration.
    The purpose of the ACMUI is to provide advice to the NRC on policy 
and technical issues that arise in regulating the medical use of 
byproduct material for diagnosis and therapy. Responsibilities include 
providing guidance and comments on current and proposed NRC regulations 
and regulatory guidance concerning medical use; evaluating certain non-
routine uses of byproduct material for medical use; and evaluating 
training and experience of proposed authorized users. The members are 
involved in preliminary discussions of major issues in determining the 
need for changes in NRC policy and regulation to ensure the continued 
safe use of byproduct material. Each member provides technical 
assistance in his/her specific area(s) of expertise, particularly with 
respect to emerging technologies. Members also provide guidance as to 
NRC's role in relation to the responsibilities of other Federal 
agencies as well as of various professional organizations and boards. 
ACMUI is in the public interest because the advice received from it 
helps the NRC ensure the safety of the public, patients, and workers 
who might be exposed to radiation from such medical usage.
    To ensure the committee has the necessary expertise and fairly 
balanced membership, members are selected based on demonstrated 
professional qualifications and expertise in both scientific and non-
scientific disciplines including nuclear medicine; nuclear cardiology; 
radiation therapy; medical physics; nuclear pharmacy; State medical 
regulation; patient's rights and care; health care administration; and 
Food and Drug Administration regulation. Because the NRC does not have 
this expertise on staff, it leverages the Committee's well-recognized 
specialists from different parts of the United States to provide advice 
and expert opinion on standards and guides used in diagnostic and 
therapeutic practices in the United States. The NRC continues to 
emphasize improving performance of medical use licensees and ACMUI's 
experts will continue to be needed to assist the Commission in this 
area. To develop and maintain a cost-effective and less burdensome in-
house capability to match the quality and quantity of expert advice 
embodied in the ACMUI is not viable. A summary of specific 
accomplishments of ACMUI over the last charter term (February 2024-
February 2026) can be reviewed at https://www.nrc.gov/about-nrc/regulatory/advisory/acmui/recomm-actions.
    ACMUI is one of three advisory committees at the NRC. The others 
are the Advisory Committee on Reactor Safeguards and the Licensing 
Support Network Advisory Review Panel.
    Estimated costs for ACMUI include federal personnel and other costs 
of $366,000; payments to members of $70,000 for 13 members; and 
reimbursable costs of $19,000.

FOR FURTHER INFORMATION CONTACT: Sarah Hoenig, Office of Nuclear 
Material Safety and Safeguards, U.S. Nuclear Regulatory Commission, 
Washington, DC 20555; Email: [email protected].

    Dated at Rockville, Maryland this 13th day of February, 2026.
    For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2026-03144 Filed 2-17-26; 8:45 am]
BILLING CODE 7590-01-P